Wednesday, March 03, 2021 11:46:11 PM
To clarify (this is new to me) - Mark Williams developed and patented Diamedica's treatment agent DM199? As used in the REMEDY trial and REDUX trial? Gotta say that is some good work.
I agree that the recent activity with private placement and Mark leaving *before* the data read-out all points to the insiders expecting a very positive result and as you say, a share price in the $1 to $5 range.
I think getting AGN listed on the NASDAQ is a stretch but who knows - in a few years, maybe that's possible. Meantime I don't mind getting PAID out of the OTC exchange. Fingers crossed that is this month.
Yeah, Kal may still F over our near-term stock chart but I've got a strategy for that. Time to plan your work and work your plan kids.
Holding the bag with a grin on my face,
Dr. E
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM